Suppliers / Nectar Lifesciences

Nectar Lifesciences

India NECLIFE.BO 2 duplicate records merged Updated 9 July 2026

Nectar Lifesciences is an API manufacturer based in India. It holds 16 active US drug master files across a filed portfolio of 9 molecules. Its filings concentrate with ARCSA (EC), ZAMRA (ZM) and TMDA (TZ). Customs aggregates show $43.8M of exports covering 556 molecules to 53 destinations in 2025.

16
active US DMFs
0
valid CEPs
2
registered plants
24
filings across 6 regulators

Registered plants

Site FDA FEI
Tehsil Dera Bassi, India Not on file
SOLAN, India Not on file

What they file, and where

Molecule Regulators Docs
Cefepime SFDA (Saudi Arabia), US FDA 4
Ceftriaxone SFDA (Saudi Arabia), US FDA 4
Cefuroxime US FDA 4
Cefotaxime SFDA (Saudi Arabia), US FDA 3
Cefixime SFDA (Saudi Arabia), US FDA 2
Cefdinir US FDA 1
Cefpodoxime US FDA 1
Ceftazidime US FDA 1
Cefuroxime Axetil SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Cefdinir API Cefepime API Cefixime API Cefotaxime API Cefpodoxime API Ceftazidime API Ceftriaxone API Cefuroxime API Cefuroxime Axetil API

Filings and GMP by regulator

Regulator Filings GMP certificates
ARCSA (EC) 5 None
ZAMRA (ZM) 5 None
TMDA (TZ) 4 None
EFDA (ET) 4 None
INVIMA (CO) 3 None
MINSA (CR) 3 None

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $104K 2
2025 $191.0M $43.8M 53
2024 $201.0M $76.3M 65
2023 $184.1M $86.0M 61

Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.

Questions about Nectar Lifesciences

Does Nectar Lifesciences hold a US DMF or a CEP?
Nectar Lifesciences holds 16 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Nectar Lifesciences manufacture?
2 registered sites are on record, in India (Tehsil Dera Bassi and Solan). Every site is listed on this page with the register it came from.
What does Nectar Lifesciences make?
9 molecules are on record against Nectar Lifesciences, including Cefepime, Ceftriaxone, Cefuroxime and Cefotaxime. Each links through to that molecule's full manufacturer list.
Where does Nectar Lifesciences file?
Filings are on record with ARCSA (EC), ZAMRA (ZM), TMDA (TZ), EFDA (ET) and 2 other regulators, 24 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Nectar Lifesciences comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Orchid Pharma shares 9 molecules Imexpharm shares 7 molecules Phil Inter Pharma shares 7 molecules Sandoz shares 6 molecules Apitoria Pharma shares 5 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts
Company filings
Revenue as reported